This is a feasibility study at a single site, Cincinnati Children's Hospital Medical Center. Patients who have undergone heart transplantation who meet eligibility requirements will be approached to participate in the study. The purpose of this study is to establish a reliable, home-based method for collecting samples as well as a standardized method for use of small-volume samples on both inpatients and outpatients.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
16
an FDA Class I medical device for direct specimen collection of blood or other biological fluids
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
Accuracy of +/-10%
A VAMS-based tacrolimus trough values will be accurate +/-10% when compared with standard whole blood values achieved via venipuncture.
Time frame: 18-24 months from start of enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.